Immune complexes alter cerebral microvessel permeability: Roles of complement and leukocyte adhesion

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 291, Issue 2, 2006, Pages

  Lister, Karyn J ^a   Hickey, Michael J ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Adhesion molecules; Cell trafficking; Inflammation

Indexed keywords

ANTIBODY; ANTIGEN; CELL ADHESION MOLECULE; IMMUNOGLOBULIN G; OVALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ARTHUS PHENOMENON; ARTICLE; BLOOD VESSEL PERMEABILITY; BRAIN; COMPLEMENT SYSTEM; CONTROLLED STUDY; EXPERIMENTAL MODEL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEUKOCYTE ADHERENCE; LEUKOCYTE COUNT; MALE; MICROVASCULATURE; MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; ARTHUS REACTION; CAPILLARY PERMEABILITY; CELL ADHESION; CELL ADHESION MOLECULES; CEREBRAL VEINS; COMPLEMENT C3; COMPLEMENT SYSTEM PROTEINS; ENDOTHELIAL CELLS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEUKOCYTE COUNT; MALE; MICE; MICE, INBRED C57BL; MICROCIRCULATION; OVALBUMIN;

EID: 33746817824     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01271.2005     Document Type: Article

References (57)

1. Adam C, Geniteau M, Gougerot-Pocidalo M, Verroust P, Lebras J, Gibert C, and Morel-Maroger L. Cryoglobulins, circulating immune complexes, and complement activation in cerebral malaria. Infect Immun 31: 530-535, 1981.
2. Allt G and Lawrenson JG. Is the pial microvessel a good model for blood-brain barrier studies? Brain Res Brain Res Rev 24: 67-76, 1997.
3. Andersson PB, Perry VH, and Gordon S. The acute inflammatory response to lipopolysaccharide in CNS parenchyma differs from that in other body tissues. Neuroscience 48: 169-186, 1992.
4. Andersson PB, Perry VH, and Gordon S. Intracerebral injection of proinflammatory cytokines or leukocyte chemotaxins induces minimal myelomonocytic cell recruitment to the parenchyma of the central nervous system. J Exp Med 176: 255-259, 1992.
5. Andres G, Brentjens JR, Caldwell PR, Camussi G, and Matsuo S. Formation of immune deposits and disease. Lab Invest 55: 510-520, 1986.
6. Ansari AA and Salahuddin A. Effects of pH, ionic strength and temperature on the ovalbumin-anti-ovalbumin precipitin reaction. Immunology 25: 377-383, 1973.
7. Atkins CJ, Kondon JJ, Quismorio FP, and Friou GJ. The choroid plexus in systemic lupus erythematosus. Ann Intern Med 76: 65-72, 1972.
8. Baumann U, Kohl J, Tschernig T, Schwerter-Strumpf K, Verbeek JS, Schmidt RE, and Gessner JE. A codominant role of FcγRI/III and C5aR in the reverse Arthus reaction. J Immunol 164: 1065-1070, 2000.
9. Boos L, Campbell IL, Ames R, Wetsel RA, and Barnum SR. Deletion of the complement anaphylatoxin C3a receptor attenuates, whereas ectopic expression of C3a in the brain exacerbates, experimental autoimmune encephalomyelitis. J Immunol 173: 4708-4714, 2004.
10. Carvalho-Tavares J, Hickey MJ, Hutchison J, Michaud J, Sutcliffe IT, and Kubes P. A role for platelets and endothelial selectins in tumor necrosis factor-α-induced leukocyte recruitment in the brain microvasculature. Circ Res 87: 1141-1148, 2000.
11. Cochrane CG. Mechanisms involved in the deposition of immune complexes in tissues. J Exp Med 134: 75s-89s, 1971.
12. Cochrane CG and Hawkins D. Studies on circulating immune complexes. 3. Factors governing the ability of circulating complexes to localize in blood vessels. J Exp Med 127: 137-154, 1968.
13. Cowell RM, Plane JM, and Silverstein FS. Complement activation contributes to hypoxic-ischemic brain injury in neonatal rats. J Neurosci 23: 9459-9468, 2003.
14. Dehring DJ, Steinberg SM, Wismar BL, Lowery BD, Carey LC, and Cloutier CT. Complement depletion in a porcine model of septic acute respiratory disease. J Trauma 27: 615-625, 1987.
15. Falangola MF, Castro-Filho BG, and Petito CK. Immune complex deposition in the choroid plexus of patients with acquired immunodeficiency syndrome. Ann Neurol 36: 437-440, 1994.
16. Fu Q, Satyaswaroop PG, and Gowda DC. Tissue targeting and plasma clearance of cobra venom factor in mice. Biochem Biophys Res Commun 231: 316-320, 1997.
17. Gloor SM, Wachtel M, Bolliger MF, Ishihara H, Landmann R, and Frei K. Molecular and cellular permeability control at the blood-brain barrier. Brain Res Brain Res Rev 36: 258-264, 2001.
18. Hayashi K, Yanagi K, and Takagi S. Detection of herpes simplex virus type 1-IgM immune complexes in the brain of a patient with prolonged herpes encephalitis. J Infect Dis 153: 56-63, 1986.
19. Henninger DD, Panes J, Eppihimer M, Russell J, Gerritsen M, Anderson DC, and Granger DN. Cytokine-induced VCAM-1 and ICAM-1 expression in different organs of the mouse. J Immunol 158: 1825-1832, 1997.
20. Ishikawa M, Cooper D, Russell J, Salter JW, Zhang JH, Nanda A, and Granger DN. Molecular determinants of the prothrombogenic and inflammatory phenotype assumed by the postischemic cerebral microcirculation. Stroke 34: 1777-1782, 2003.
21. Ishikawa M, Vowinkel T, Stokes KY, Arumugam TV, Yilmaz G, Nanda A, and Granger DN. CD40/CD40 ligand signaling in mouse cerebral microvasculature after focal ischemia/reperfusion. Circulation 111: 1690-1696, 2005.
22. lpr mice. J Immunol 170: 520-527, 2003.
23. Kawamura S, Schurer L, Goetz A, Kempski O, Schmucker B, and Baethmann A. An improved closed cranial window technique for investigation of blood-brain barrier function and cerebral vasomotor control in the rat. Int J Microcirc Clin Exp 9: 369-383, 1990.
24. 4-integrin to recruit leukocytes to the central nervous system in experimental autoimmune encephalomyelitis. J Immunol 169: 1000-1006, 2002.
25. Kerfoot SM, Long EM, Hickey MJ, Andonegui G, Lapointe BM, Zanardo RC, Bonder C, James WG, Robbins SM, and Kubes P. TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease. J Immunol 173: 7070-7077, 2004.
26. Kock MA, Hew BE, Bammert H, Fritzinger DC, and Vogel CW. Structure and function of recombinant cobra venom factor. J Biol Chem 279: 30836-30843, 2004.
27. Kohl J and Gessner JE. On the role of complement and Fcγ-receptors in the Arthus reaction. Mol Immunol 36: 893-903, 1999.
28. Kurose I, Wolf R, Grisham MB, Aw TY, Specian RD, and Granger DN. Microvascular responses to inhibition of nitric oxide production. Role of active oxidants. Circ Res 76: 30-39, 1995.
29. Lahita RG. Systemic Lupus Erythematosus (3rd ed.). San Diego, CA: Academic, 1999.
30. Lew AM, Staines NA, and Steward MW. Glomerulonephritis induced by pre-formed immune complexes containing monoclonal antibodies of defined affinity and isotype. Clin Exp Immunol 57: 413-422, 1984.
31. Lukacs NW, Glovsky MM, and Ward PA. Complement-dependent immune complex-induced bronchial inflammation and hyperreactivity. Am J Physiol Lung Cell Mol Physiol 280: L512-L518, 2001.
32. Mayhan WG and Heistad DD. Permeability of blood-brain barrier to various-sized molecules. Am J Physiol Heart Circ Physiol 248: H712-H718, 1985.
33. Meng W, Ma J, Ayata C, Hara H, Huang PL, Fishman MC, and Moskowitz MA. ACh dilates pial arterioles in endothelial and neuronal NOS knockout mice by NO-dependent mechanisms. Am J Physiol Heart Circ Physiol 271: H1145-H1150, 1996.
34. Morgan BP, Gasque P, Singhrao S, and Piddlesden SJ. The role of complement in disorders of the nervous system. Immunopharmacology 38: 43-50, 1997.
35. 2-integrins and ICAM-1 in lung injury after deposition of IgG and IgA immune complexes. J Immunol 150: 2407-2417, 1993.
36. Nataf S, Carroll SL, Wetsel RA, Szalai AJ, and Barnum SR. Attenuation of experimental autoimmune demyelination in complement-deficient mice. J Immunol 165: 5867-5873, 2000.
37. Norman KE, Argenbright LW, Williams TJ, and Rossi AG. Role of adhesion glycoproteins CD18 and intercellular adhesion molecule-1 in complement-mediated reactions of rabbit skin. Br J Pharmacol 111: 117-122, 1994.
38. Norman MU, Lew RA, Smith AI, and Hickey MJ. Metalloendopeptidases EC 3.4.24.15/16 regulate bradykinin activity in the cerebral microvasculature. Am J Physiol Heart Circ Physiol 284: H1942-H1948, 2003.
39. Norman MU, Lister KJ, Yang YH, Issekutz A, and Hickey MJ. TNF regulates leukocyte-endothelial cell interactions and microvascular dysfunction during immune complex-mediated inflammation. Br J Pharmacol 144: 265-274, 2005.
40. Norman MU, Van De Velde NC, Timoshanko JR, Issekutz A, and Hickey MJ. Overlapping roles of endothelial selectins and vascular cell adhesion molecule-1 in immune complex-induced leukocyte recruitment in the cremasteric microvasculature. Am J Pathol 163: 1491-1503, 2003.
41. Pittella JE and Bambirra EA. Immune complexes in the choroid plexus in liver cirrhosis. Arch Pathol Lab Med 115: 220-222, 1991.
42. Pittella JE and Bambirra EA. Immune complexes in the choroid plexus in systemic hypertension. J Clin Pathol 41: 1245-1246, 1988.
43. Ransohoff RM, Kivisakk P, and Kidd G. Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol 3: 569-581, 2003.
44. Sahagun G, Moore SA, Fabry Z, Schelper RL, and Hart MN. Purification of murine endothelial cell cultures by flow cytometry using fluorescein-labeled Griffonia simplicifolia agglutinin. Am J Pathol 134: 1227-1232, 1989.
45. Santos LL, Huang XR, Berndt MC, and Holdsworth SR. P-selectin requirement for neutrophil accumulation and injury in the direct passive Arthus reaction. Clin Exp Immunol 112: 281-286, 1998.
46. Singhrao SK, Neal JW, Morgan BP, and Gasque P. Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease. Exp Neurol 159: 362-376, 1999.
47. Song X, Shapiro S, Goldman DL, Casadevall A, Scharff M, and Lee SC. Fcγ receptor I- and III-mediated macrophage inflammatory protein 1α induction in primary human and murine microglia. Infect Immun 70: 5177-5184, 2002.
48. Song X, Tanaka S, Cox D, and Lee SC. Fcγ receptor signaling in primary human microglia: differential roles of PI-3K and Ras/ERK MAPK pathways in phagocytosis and chemokine induction. J Leukoc Biol 75: 1147-1155, 2004.
49. Stokol T, O'Donnell P, Xiao L, Knight S, Stavrakis G, Botto M, von Andrian UH, and Mayadas TN. C1q governs deposition of circulating immune complexes and leukocyte Fcγ receptors mediate subsequent neutrophil recruitment. J Exp Med 200: 835-846, 2004.
50. Sylvestre DL and Ravetch JV. Fc receptors initiate the Arthus reaction: redefining the inflammatory cascade. Science 265: 1095-1098, 1994.
51. Teixeira MM, Fairbairn SM, Norman KE, Williams TJ, Rossi AG, and Hellewell PG. Studies on the mechanisms involved in the inflammatory response in a reversed passive Arthus reaction in guinea-pig skin: contribution of neutrophils and endogenous mediators. Br J Pharmacol 113: 1363-1371, 1994.
52. Teixeira MM, Reynia S, Robinson M, Shock A, Williams TJ, Williams FM, Rossi AG, and Hellewell PG. Role of CD18 in the accumulation of eosinophils and neutrophils and local oedema formation in inflammatory reactions in guinea-pig skin. Br J Pharmacol 111: 811-818, 1994.
53. 4-Integrin- VCAM-1 binding mediates G protein-independent capture of encephalitogenic T cell blasts to CNS white matter microvessels. J Clin Invest 108: 557-565, 2001.
54. Van Beek J, Elward K, and Gasque P. Activation of complement in the central nervous system: roles in neurodegeneration and neuroprotection. Ann NY Acad Sci 992: 56-71, 2003.
55. Wajgt A, Gorny MK, and Jenek R. The influence of high-dose prednisone medication on autoantibody specific activity and on circulating immune complex level in cerebrospinal fluid of multiple sclerosis patients. Acta Neurol Scand 68: 378-385, 1983.
56. Winfield JB, Shaw M, Silverman LM, Eisenberg RA, Wilson HA III, and Koffler D. Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction. Am J Med 74: 837-844, 1983.
57. Yong T, Zheng MQ, and Linthicum DS. Nicotine induces leukocyte rolling and adhesion in the cerebral microcirculation of the mouse. J Neuroimmunol 80: 158-164, 1997.